Clinical trial / 2020
Melissa officinalis and Lavandula angustifolia showed effects similar to fluoxetine in treating mild to moderate depression over 8 weeks.
An 8-week double-blind randomized clinical trial compared Melissa officinalis (2 g/day), Lavandula angustifolia (2 g/day), and fluoxetine (20 mg/day) in 45 adult outpatients with mild to moderate major depression. Outcomes were measured at weeks 0, 2, 4, and 8 using the 17-item HAM-D. The study found that M. officinalis and L. angustifolia had an effect similar to fluoxetine (F = 0.131, df = 2,42, p = 0.877). A notable limitation stated by the authors was the absence of a placebo group.
- Study type
- Randomized, double-blind pilot trial
- Who was studied
- 45 adult outpatients with DSM-5 major depression (mild to moderate)
- What was measured
- Depression scores on the 17-item Hamilton Rating Scale for Depression (HAM-D)
THE PAPER
A double-blind, randomized pilot study for comparison of Melissa officinalis L. and Lavandula angustifolia Mill. with Fluoxetine for the treatment of depression.
Araj-Khodaei M, Noorbala AA, Yarani R, Emadi F, Emaratkar E, Faghihzadeh S, Parsian Z, Alijaniha F, Kamalinejad M, Naseri M. BMC Complement Med Ther, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.